R Squared’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
R Squared's REGN Position: Q2 2026 in Review
R Squared opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 902 shares worth $562K. The stake represents 0.3% of the portfolio and ranks #85 among its holdings. This is a return to the name: R Squared previously reported a position in REGN as recently as Q2 2025.
R Squared first reported a position in REGN in Q4 2024 and has held it in 4 quarters since. 1,334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- R Squared held 902 shares of Regeneron Pharmaceuticals worth $562K as of Q2 2026.
- Regeneron Pharmaceuticals was a new R Squared position in Q2 2026.
- Regeneron Pharmaceuticals made up 0.3% of R Squared's portfolio in Q2 2026, its #85 holding.
- R Squared first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
- 1,334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.